Industry Capture: How the Sugar Industry Shaped Nutritional Science
The story of industry influence on nutritional science is not a conspiracy theory. It is a documented historical record that has been reconstructed from industry archives, academic correspondence, and Freedom of Information Act requests. The primary mechanism of industry influence was not falsification of data but strategic funding of research designed to produce favorable conclusions, strategic suppression of unfavorable findings, and strategic placement of industry-funded scientists in positions of policy influence.
Understanding this history is clinically relevant because the dietary guidelines that physicians are trained to follow (and that patients are advised to follow) were shaped in significant part by industry-funded science and industry-influenced policy. The physician who is unaware of this history may be providing dietary advice that reflects industry interests more than patient health.
The Sugar Research Foundation Documents
In 2016, Cristin Kearns, Laura Schmidt, and Stanton Glantz published a landmark paper in JAMA Internal Medicine revealing the contents of internal Sugar Research Foundation (SRF) documents from the 1960s. The documents showed that the SRF (the research arm of the sugar industry) had paid Harvard researchers, including D. Mark Hegsted and Fredrick Stare, approximately $50,000 (equivalent to approximately $400,000 in 2016 dollars) to produce a series of literature reviews on dietary fat, dietary sugar, and cardiovascular disease.
The reviews, published in the New England Journal of Medicine in 1967 under the authorship of Hegsted and colleagues, concluded that dietary sugar was not a significant contributor to cardiovascular disease and that the primary dietary risk factor was saturated fat. The reviews selectively cited studies that supported this conclusion and dismissed or minimized studies that contradicted it. The financial relationship between the SRF and the Harvard researchers was not disclosed. A violation of scientific ethics that was not standard practice at the time but would be considered a serious conflict of interest by contemporary standards.
"Industry-funded studies are 4 to 8 times more likely to produce results favorable to the funder. The mechanism is not primarily fraud, it is the selection of research questions and the decision of whether to publish.
The significance of this funding is not merely that the Harvard researchers were paid by the sugar industry. It is that D. Mark Hegsted (one of the authors of the SRF-funded reviews) subsequently became the lead nutrition scientist at the USDA and was the primary author of the 1977 Dietary Goals for the United States, which established the low-fat dietary paradigm as national policy. The scientist who had been paid by the sugar industry to minimize sugar's role in cardiovascular disease became the architect of the dietary guidelines that millions of Americans were advised to follow.
The USDA Food Pyramid and Industry Lobbying
The 1992 USDA Food Pyramid. Which placed grains at the base (6–11 servings per day) and fats at the apex (use sparingly). Was the most visible expression of the low-fat dietary paradigm and the most influential dietary guidance document in American history. What is less well known is the extent to which the Food Pyramid's design was influenced by food industry lobbying.
The original USDA Food Pyramid, developed by nutritionist Luise Light and her team in the 1980s, recommended 3–4 servings of whole grains per day and placed a much greater emphasis on vegetables and fruits. When the pyramid was reviewed by USDA administrators and food industry representatives, the grain recommendation was increased to 6–11 servings (a change that Light later attributed to pressure from the grain and bread industries). The final pyramid, published in 1992, was a document shaped as much by industry interests as by nutritional science.
Trans Fats: A Case Study in Regulatory Capture
The history of trans fats provides a particularly clear case study in how industry influence can delay regulatory action on a known health hazard. Trans fats (produced by partial hydrogenation of vegetable oils) were introduced into the food supply in the early twentieth century as a cheaper, more shelf-stable alternative to animal fats. By the 1990s, the evidence that trans fats raised LDL-C, lowered HDL-C, and increased cardiovascular risk was substantial and growing.
The FDA did not require trans fat labeling on food products until 2006 (more than a decade after the evidence of harm was clear) and did not ban trans fats from the food supply until 2018. During the intervening decades, the food industry lobbied aggressively against trans fat regulation, funding research that minimized the evidence of harm and arguing that the evidence was insufficient to justify regulatory action. The delay in regulatory action is estimated to have contributed to tens of thousands of preventable cardiovascular deaths per year.
The Ongoing Challenge of Industry-Funded Research
The influence of industry funding on nutritional research is not a historical artifact. It is an ongoing challenge. A systematic review by Bes-Rastrollo et al. (2013) found that industry-funded studies of sugar-sweetened beverages were 5 times more likely to find no association with obesity than studies without industry funding. A review by Kearns et al. (2015) found that sugar industry funding was associated with significantly more favorable conclusions about sugar's metabolic effects.
The mechanism of industry influence is not primarily outright fraud. It is the selection of research questions, study designs, and analytical approaches that are more likely to produce favorable results. Industry-funded researchers are not necessarily dishonest; they are operating within a funding environment that systematically selects for favorable findings. The result is a body of literature that is systematically biased toward industry-favorable conclusions, and a regulatory environment that relies heavily on that literature.
The clinical implication is that physicians should be aware of the funding sources of the nutritional research they rely on, and should weight industry-funded observational studies significantly less than independent RCTs. The most reliable evidence for dietary interventions comes from well-designed randomized controlled trials with no industry funding. And as the history of the Minnesota Coronary Experiment and Sydney Diet Heart Study demonstrates, even RCT results are not immune to suppression when they contradict industry interests.